News

The latest from Orpyx

Orpyx® Receives Award for "Coolest Technology"

Calgary, AB April 21, 2015 - Orpyx Medical Technologies Inc. (“Orpyx”) participated in the pitch competition at the 48 Hours in the Hub event, an annual intensive two-day program in Cambridge/Boston. Orpyx’s President, Lew Turnquist, competed against other Canadian companies in the Life Sciences/ Health IT stream and was awarded the prize for “Coolest Technology”. The award was delivered by Gaurav Jain, who was recently named one of Forbes’ 30 under 30 in Venture Capital 2015.

The Consulate General of Canada in Boston and the Canadian Entrepreneurs in New England (CENE) selected 24 innovative Canadian companies to participate in the 48 Hours in the Hub event. It is an opportunity for Canadian companies to gain visibility in the local Boston business and investment community.

ABOUT CENE:

The CENE (Canadian Entrepreneurs in New England) is a non-profit, member-driven organization dedicated to supporting Canadian technology and life science entrepreneurship. It is comprised of a select group of Canadians based primarily in the U.S., including executives of leading technology and life-sciences companies, experienced start-up entrepreneurs and venture capital investors. 


ABOUT ORPYX MEDICAL TECHNOLOGIES:

Orpyx is a wearable pressure sensor technology company focused on medical applications. To start, Orpyx’s primary intention is to address the world’s growing epidemic of diabetes and its associated complications, most notably, lack of circulation, numbness, infection and ulcers in the feet, also known as peripheral neuropathy. This problem affects upwards of 60% of diabetics over the course of their disease and costs the health care system over $14 billion annually.

The SurroSense Rx system is a tool to help actively prevent the complications associated with peripheral neuropathy and track progress. The system is comprised of pressure-sensing inserts that wirelessly transmit feedback to the user via smartwatch or mobile application. The display alerts the user as to when pressure-induced damage is occurring so that behaviour can be proactively changed and devastating complications avoided.

In addition to the benefits of having real-time feedback, the system also tracks compliance and performance metrics over time so that the patient and primary care team and monitor progress and adjust care recommendations accordingly.

For more information, please contact:

Stephanie Zakala
Marketing & Inside Sales Manager, Orpyx Medical Technologies Inc.
stephanie.zakala@orpyx.com
403-460-0216

Orpyx® presented to a funding panel in Edmonton, Alberta and was awarded top honours.  The Fundica Fundraising Roadshow is an opportunity for companies to pitch their innovative product to an esteemed panel of VC, banks and government organizations.  Read about the event here.

Orpyx® has been announced as one of the twenty-seven companies in western Canada to receive funding under the WINN initiative.  WINN is a government program committed to creating jobs, promoting economic growth, and maintaining Canada's competitive advantage in the global marketplace.

Read more here.

The 24th annual ASTech Awards Gala was a spectacular night showcasing innovation and leading edge technologies from Alberta. The evening highlighted many aspects of Alberta's innovation potential and honoured the achievements of individuals and organizations that are advancing science and technology fields.  Orpyx received the award for Outstanding Science and Technology Start-Up sponsored by NAIT. Read more here.

Orpyx® Medical Technologies was announced the grand-prize winner at the 2013 TEC Edmonton VenturePrize Awards in the Fast Growth category.  This win marks three competition firsts in over a decade including: the first ever female-led company to win, first winner from Calgary, and the first company to win Student and Fast Growth competitions back-to-back. 

Calgary, AB - April 19, 2013 - Orpyx Medical Technologies was thrilled to have been awarded top honours at the 2013 TEC Edmonton VenturePrize Awards.  The competition, hosted by TEC Edmonton, recognizes and awards Alberta's top innovative and high-tech companies.  Orpyx was awarded with $100,000 in cash and in-kind services.  TEC VenturePrize is a program of TEC Edmonton, that provides training, professional support and financial incentives to help people build or enhance a viable high-growth business.

The win was a major feat for Calgary-based Orpyx.  The company made VenturePrize history as the first ever female-led company winner, first winner from Calgary and the first company to win the Student and Fast Growth VenturePrize competitions back-to-back.

“We are absolutely elated to have been awarded this year's TECVenture Fast Growth Grand Prize.  We could not be happier with the support we have received from the Alberta Tech community, and this is really the culmination of that backing.  This award will be completely invaluable in continuing to grow Orpyx, and ultimately, helping us to save limbs and save lives" states Dr. Breanne Everett, CEO and President of Orpyx Medical Technologies. 

Alberta fosters an amazing innovation and entrepreneurial environment, which can be seen in the group of finalists.  Orpyx was up against two formidable competitors including Surface Medical Inc. from Calgary and LoginRadius from Edmonton.  Orpyx plans on applying the VenturePrize Award towards the commercialization of their flagship product, the SurroSense Rx, which will be available later this year.

For more info, please contact:

Stephanie Zakala
Marketing & Communications Associate, Orpyx Medical Technologies Inc.
(403) 709-0129
stephanie.zakala@orpyx.com

About Orpyx Medical Technologies Inc.:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.

About TEC Edmonton:

TEC Edmonton helps transform high-tech discoveries into viable business opportunities.  Through our business services, TEC Edmonton helps navigate the commercialization process by providing assistance with technology evaluation, intellectual property protection, business plan development, marketing research, corporate management and funding preparation - as well as provides a home for startups in the TEC Centre incubation facility.  For more information, visit www.tecedmonton.com.

Orpyx® Medical Technologies was announced the grand-prize winner at the 2013 TEC Edmonton VenturePrize Awards in the Fast Growth category.  This win marks three competition firsts in over a decade including: the first ever female-led company to win, first winner from Calgary, and the first company to win Student and Fast Growth competitions back-to-back. 

Calgary, AB - April 19, 2013 - Orpyx Medical Technologies was thrilled to have been awarded top honours at the 2013 TEC Edmonton VenturePrize Awards.  The competition, hosted by TEC Edmonton, recognizes and awards Alberta's top innovative and high-tech companies.  Orpyx was awarded with $100,000 in cash and in-kind services.  TEC VenturePrize is a program of TEC Edmonton, that provides training, professional support and financial incentives to help people build or enhance a viable high-growth business.

The win was a major feat for Calgary-based Orpyx.  The company made VenturePrize history as the first ever female-led company winner, first winner from Calgary and the first company to win the Student and Fast Growth VenturePrize competitions back-to-back.

“We are absolutely elated to have been awarded this year's TECVenture Fast Growth Grand Prize.  We could not be happier with the support we have received from the Alberta Tech community, and this is really the culmination of that backing.  This award will be completely invaluable in continuing to grow Orpyx, and ultimately, helping us to save limbs and save lives" states Dr. Breanne Everett, CEO and President of Orpyx Medical Technologies. 

Alberta fosters an amazing innovation and entrepreneurial environment, which can be seen in the group of finalists.  Orpyx was up against two formidable competitors including Surface Medical Inc. from Calgary and LoginRadius from Edmonton.  Orpyx plans on applying the VenturePrize Award towards the commercialization of their flagship product, the SurroSense Rx, which will be available later this year.

For more info, please contact:

Stephanie Zakala
Marketing & Communications Associate, Orpyx Medical Technologies Inc.
(403) 709-0129
stephanie.zakala@orpyx.com

About Orpyx Medical Technologies Inc.:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.

About TEC Edmonton:

TEC Edmonton helps transform high-tech discoveries into viable business opportunities.  Through our business services, TEC Edmonton helps navigate the commercialization process by providing assistance with technology evaluation, intellectual property protection, business plan development, marketing research, corporate management and funding preparation - as well as provides a home for startups in the TEC Centre incubation facility.  For more information, visit www.tecedmonton.com.

2013 TIPS Innovation Challenge

February 14, 2013

Awards  

To foster the development of the best new technology and innovations in the field of cosmetic & reconstructive surgery the Plastic Surgery Foundation launched the inaugural TIPS Innovation Challenge.  Orpyx® was selected as one of the top two submissions with the best technological inventions.
Orpyx® CEO, Dr. Breanne Everett, was recognized as one of Avenue Magazine's Top 40 Under 40. When the issue was revealed at an industry gala event at Downtown Calgary's CORE on November 1, 2012, Breanne was surprised to learn that her photo made the cover! Avenue Calgary‘s Top 40 Under 40 celebrates Calgarians under the age of 40 who excel in their respective fields, give back to their community & raise the profile of the city. Read the article.

Orpyx was honored with $20k at the TEC Edmonton VenturePrize Awards in the Student Business Plan category. The competition included a gamut of impressive technology start-ups from across the province pitching their concepts to a roomful of technology movers and shakers. 

Calgary, AB - May 7, 2012 - Orpyx Medical Technologies was one of a number of Alberta-based companies competing for cash and in-kind goods and services at the 10th Annual TEC Edmonton VenturePrize Awards in Edmonton last week. TEC VenturePrize is a program of TEC Edmonton, providing training, professional support and financial incentives to help people build or enhance a viable technology-based business. The competition marked the final round of a series of regional business plan competitions held in the months leading up to the VenturePrize event. After winning the Calgary-region Student Technology Innovation Challenge (STIC) in February, Dr. Breanne Everett presented Orpyx’s business plan to a panel of judges in Edmonton. After an amazing evening packed with inspirational speeches and presentations, Orpyx was announced as the winner in their category.

“We are so thrilled and honoured to have been recognized at the VenturePrize Awards, among a truly amazing group of up-and-coming companies,” says Dr. Breanne Everett, CEO and President, Orpyx Medical Technologies. “TEC Edmonton has been such a supportive community—a tremendous asset to an emerging company. It's a very exciting time to be in Alberta and part of the growing innovation scene.”

The other two companies competing in the Student Business Plan finals were CitizenBridge from the University of Lethbridge, and ENERCAL Data Systems from the University of Calgary. Everyone in attendance agreed that without the resources, mentorship and financial support made available through agencies such TEC Edmonton and Innovate Calgary, the viability of tech-based businesses  in Alberta would be substantially compromised. Orpyx plans on applying their VenturePrize Award towards their technology development costs and commercialization goals for late 2012.

For more info, please contact:

Amanda Hehr
VP Marketing, Orpyx Medical Technologies Inc.
M (403) 805-6446
O (403) 709-0129
amanda.hehr@orpyx.com

About Orpyx Medical Technologies Inc.:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by 27-year-old Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user using the ANT+ wireless technology protocol.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.

About TEC Edmonton:

TEC Edmonton helps transform high-tech discoveries into viable business opportunities. Through our business services, TEC Edmonton helps navigate the commercialization process by providing assistance with technology evaluation, intellectual property protection, business plan development, marketing research, corporate management and funding preparation – as well as provides a home for startups in the TEC Centre incubation facility. A unique non-for-profit enterprise, TEC Edmonton is a joint venture between Edmonton Economic Development Corporation (EEDC) and the University of Alberta. For more information visit www.tecedmonton.com.